/
Other
Bowel Preparation
18
Pipeline Programs↗
20
Active Trials↗
6
Companies Involved↗
Bowel Preparation is an emerging landscape with 18 programs across 6 companies. The most active players are Ferring. 5 programs are in Phase 3.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
Preclinical12
Phase 2
No programs
Phase 35
Approved
No programs
Analysis
Modality Breakdown
94%
Small molecule
16 of 17 classified programs — the dominant modality here.
Small molecule leads; the ring shows all 17 classified programs, each share of the total. Modality classified for 94% of 18 pipeline programs.
Analysis
Trial Status
132
clinical trials
Completed83 · 63%
Unknown status20 · 15%
Recruiting11 · 8%
Terminated7 · 5%
Not yet recruiting4 · 3%
Active, not recruiting3 · 2%
Other4 · 3%
Clinical Trials
Trial Activity
132 trials
Clinical Study of PEG Bowel Preparation in Appendectomy Patients
Recruiting·—·N/A·NCT07478029·10 enrolled
Impact of PEG Bowel Preparation on Gut Microbiome Composition Recovery
Recruiting·—·Phase 1·NCT06831539·20 enrolled
Page 1 of 9
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)